← back to search

Michael Tu

Emory University · US
Area of research
Infectious Diseases · Physiology
Research interest
Research interests include Salivary Gland Disorders and Functions, SARS-CoV-2 and COVID-19 Research, Cancer Genomics and Diagnostics, and SARS-CoV-2 detection and testing.
h-index
18
citations
1,941
works
76
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
Cell Reports Medicine 2023cited by 192position: middledoi
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Cancers 2021cited by 26position: middledoi
Acoustofluidic Salivary Exosome Isolation
Journal of Molecular Diagnostics 2019cited by 151position: middledoi
Clinical validity of saliva and novel technology for cancer detection
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019cited by 139position: middledoi
Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions
Clinical Oral Investigations 2018cited by 44position: middledoi
Saliva Liquid Biopsy for Point-of-Care Applications
Frontiers in Public Health 2017cited by 131position: lastdoi
Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection
Amino Acids 2017cited by 78position: middledoi
Saliva diagnostics – Current views and directions
Experimental Biology and Medicine 2016cited by 466position: middledoi
Emerging technologies for salivaomics in cancer detection
Journal of Cellular and Molecular Medicine 2016cited by 79position: middledoi
Oral Biofluid Biomarker Research: Current Status and Emerging Frontiers
Diagnostics 2016cited by 69position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David T. Wong · University of California, Los Angeles8 papers (2016–2021)Wei Fang · East China Jiaotong University4 papers (2016–2021)Jordan Cheng · University of California, Los Angeles3 papers (2019–2021)Karolina Elżbieta Kaczor‐Urbanowicz · QB33 papers (2016–2019)Franklin García‐Godoy · University of Tennessee at Knoxville2 papers (2016–2016)— · 2 papers (2017–2018)Yong H. Kim · Sanofi (France)2 papers (2019–2019)David Chia · Guy's and St Thomas' NHS Foundation Trust2 papers (2019–2021)Katri Aro · University of Helsinki2 papers (2016–2017)Carmen Martín Carreras‐Presas · Universidade de Santiago de Compostela2 papers (2016–2016)— · 2 papers (2017–2018)Feng Li · UCLA Health2 papers (2018–2019)Shigeo Ishikawa · Yamagata University2 papers (2017–2018)Elliot Abemayor · University of California, Los Angeles1 papers (2019–2019)Heebum Shin · University of California, Los Angeles1 papers (2019–2019)Hisham Mehanna · Queen Elizabeth Hospital Birmingham1 papers (2019–2019)Udayan Guha · Beltsville Agricultural Research Center1 papers (2021–2021)Nitin Roper · National Cancer Institute1 papers (2021–2021)— · 1 papers (2017–2017)Elizabeth Akoth · Center for Cancer Research1 papers (2021–2021)